Clinical trial
Use of Montelukast to Treat Children With Mild to Moderate Acute Asthma
NCT00213252 · The Hospital for Sick Children, Other · Completed
Key facts
| NCT number | NCT00213252 |
|---|---|
| Title | Use of Montelukast to Treat Children With Mild to Moderate Acute Asthma |
| Official title | Can Montelukast Shorten Corticosteroid Therapy In Children With Mild To Moderate Acute Asthma? |
| Lead sponsor | The Hospital for Sick Children, Other |
| Collaborators | Merck Frosst Canada Ltd. Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Asthma, Bronchial |
| Intervention type | Drug |
| Interventions | Montelukast plus prednisolone, Prednisolone |
| Enrollment | 130 |
| Start date | Sep 1, 2005 |
| Primary completion | Feb 1, 2008 |
| Completion | Feb 1, 2008 |
| First posted | Sep 21, 2005 |
| Last update posted | May 13, 2014 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: